Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy

Évanguelos Xylinas(NewYork–Presbyterian Hospital), Shahrokh F. Shariat(Universitätszahnklinik Wien), Yair Lotan(Southwestern Medical Center), Giacomo Novara(University of Padua), Marc Zerbib(Université Paris Cité), Douglas S. Scherr(Cornell University), Thomas Clozel(Owl Research Institute), Francesco Montorsi(Vita-Salute San Raffaele University), Morgan Rouprêt(Sorbonne Université), Michael Rink(Marienkrankenhaus Hamburg), Quoc‐Dien Trinh(University of Pittsburgh Medical Center), Evi Comploj(Ospedale di Bolzano), Vitaly Margulis(Southwestern Medical Center), Richard K. Lee(NewYork–Presbyterian Hospital), Pierre I. Karakiewicz(Université de Montréal), Armin Pycha(Sigmund Freud Privatuniversität Wien), Jay D. Raman(Penn State Milton S. Hershey Medical Center), Alon Z. Weizer(University of Michigan), Vincenzo Ficarra(University of Padua), Christian Seitz(Medical University of Vienna)
British Journal of Urology
March 6, 2013
Cited by 165


Related Papers